Phase III Presbyopia Correction Using the VIS Opti-K™ System (NCT06487897)
Phase III Presbyopia Correction Using the VIS Optimal Keratoplasty (Opti-K™) System (Phase IIIa)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to evaluate the safety and efficacy of using the VIS Opti-K System to enable monovision by providing temporary improvement in near vision through the treatment of the non-dominant eye of low myopic, emmetropic and low hyperopic presbyope subjects. The main questions it aims to answer are determining uncorrected near visual acuity at 40cm in the treated eye and subjective improvement as measured by the patient satisfaction questionnaire.
Who can join: Review the eligibility criteria below.
Location: Cohen Laser & Vision Center — Boca Raton, Florida
Age range: 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Cohen Laser & Vision Center — Boca Raton, Florida
- Claris Vision Eye Health — South Dartmouth, Massachusetts
- The Cornea & Laser Eye Institute — Teaneck, New Jersey
- OCLI Vision - Oceanside — Oceanside, New York
📞 Contact the Study Coordinator
Phone: (214) 855-1222
Email: kwort@totalcro.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Presbyopia
- Quantitative Refractive Crosslinking in Presbyopia Aged Patients — Rio de Janeiro,
- Contact Lens Trial Fitting Experience — Bellaire, Texas
- Quality of Life in Presbyopic Patients Who Are Treated With Qlosi — Medina, Minnesota
- Performance of Two Daily Disposable Multifocal Contact Lenses — Berkeley, California
Explore by condition: All Presbyopia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.